Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Trial ID or NCT#
NCT04579588
Status
RECRUITING
Purpose
The purpose of this study is to measure immunity to the flu vaccine over time in patients who had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Official Title
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Eligibility Criteria
Ages Eligible for Study: 18 Years to 64 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- - Adults enrolled in study 55689 (NCT04373148) or the general population - Adults diagnosed with severe or moderate COVID-19 at least 2 months prior enrollment - Adults without COVID-19 diagnosis for controls
Exclusion Criteria:
- - Received the influenza vaccine less than 4 months ago - Pregnant or lactating - Patients with special risks attendant to venipuncture - Use of immunomodulatory medications - Immunodeficiency or autoimmune disease
Investigator(s)
Kari Nadeau, MD, PhD
Contact us to find out if this trial is right for you.
Contact
SNP Center Inquiry
650-521-7237
View on ClinicalTrials.gov